The LEAPS methodology begins by answering two structured questions: what evidence to produce, and how to produce it, as outlined in this two-part Research Brief series: • Part I: Baking … Read More
NEWDIGS hosts first Paying for Cures Workshop at MIT
Daylong session gathered leaders from across the national healthcare innovation landscape The NEWDIGS Initiative at the Massachusetts Institute of Technology held a Paying for Cures Workshop on August 7, attended … Read More
NEWDIGS turns 10!
Letter from Dr Gigi Hirsch Executive Director, MIT Center for Biomedical Innovation and Director, NEWDIGS In 2009 an international working group of biomedical research and healthcare leaders gathered at MIT … Read More
LEAPS Design Lab at MIT advances work on Massachusetts-wide rheumatoid arthritis “learning engine”
The LEAPS Project in the MIT Center for Biomedical Innovation’s NEWDIGS Initiative held its third Design Lab June 18–19 at MIT. It was well attended by leaders and innovators across … Read More
Arthritis Foundation joins NEWDIGS LEAPS Project
Consortium dedicated to launching a healthcare system-wide “learning engine” for rheumatoid arthritis in Massachusetts The Arthritis Foundation has joined the NEWDIGS Initiative at the Massachusetts Institute of Technology Center for … Read More
Payer Perspectives Survey
A survey of 77 payers representing over 280 million lives, completed in April 2019, explored perspectives concerning financing challenges and management strategies associated with durable cell and gene therapies. Download … Read More
Gigi Hirsch speaks about Dynamic Dossier in the Cloud project at Sanofi
On June 11, 2019, MIT Center for Biomedical Innovation Executive Director Gigi Hirsch, MD, addressed the 4th Regulatory Innovation Evening held at Sanofi. This event brings pharmaceutical and regulatory professionals together … Read More
Estimating the Clinical Pipeline of Cell and Gene Therapies and Their Potential Economic Impact on the US Healthcare System
Value in Health, June 2019Casey Quinn, Colin Young, Jonathan Thomas, and Mark Trusheim Cell and gene therapies promise durable clinical benefit from a single treatment course. High upfront reimbursement for … Read More
Are Payers Ready, Willing, and Able to Provide Access to New Durable Gene Therapies?
Value in Health, June 2019Jane F. Barlow, Mo Yang, and J. Russell Teagarden Access to new gene therapies may be impacted by payer ability to absorb the cost of coverage. … Read More
American College of Rheumatology joins NEWDIGS LEAPS Project
Initiative to design a systemwide “learning engine” for rheumatoid arthritis in Massachusetts The American College of Rheumatology (ACR), an international medical association that serves more than 8,500 members of the … Read More